The role of urologists in working with medical oncologists to treat patients with advanced prostate cancer, with special considerations for early referral.
Benjamin H. Lowentritt, MD, FACS
Advertisement
Articles by Benjamin H. Lowentritt, MD, FACS
Advertisement
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5